Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Summary

This phase II trial studies how well romiplostim works in increasing low platelet counts in patients with multiple myeloma receiving chemotherapy. Romiplostim may cause the body to make platelets after chemotherapy

Timeline

Start

2013-01

Primary completion

2015-11

Completion

2015-11

Outcome

Outcome not reported

Stopped: “PI left the institution”

Drugs

Indications